Fetzima 40 mg/1 (Levomilnacipran Hydrochloride CAPSULE, EXTENDED RELEASE) 40 mg/1

Fetzima 40 mg is an extended-release capsule containing levomilnacpran hydrochloride, used for managing depression. This medication is designed to provide sustained relief and is available in a convenient 90-capsule pack.

Strength

40 mg/1

Pack Size

90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0456-2240-90)

Manufacturer / TM Owner

Allergan, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Fetzima 40 mg is primarily used for the management of major depressive disorder (MDD). It works by affecting certain chemicals in the brain that may be unbalanced in people with depression. This medication is designed to help improve mood, sleep, appetite, and energy levels. People often ask, 'What is Fetzima used for?' and the answer is that it is typically prescribed for long-term management of depressive symptoms.

Side Effects

Common effects of Fetzima 40 mg may include nausea, dry mouth, constipation, and increased sweating. Some users may also experience dizziness or insomnia. These effects can vary from person to person and may subside as the body adjusts to the medication. It's important to consult a healthcare provider if any effects are severe or persistent.

Precautions & Warnings

Fetzima 40 mg should be handled with care. It is important to follow the prescribed dosage and not to crush or chew the extended-release capsules. This medication should be stored at room temperature, away from moisture and heat. Always inform your healthcare provider about any other medications you are taking to avoid potential interactions.

Avoid Interactions

Fetzima 40 mg may interact with other medications, including those that affect serotonin levels, such as SSRIs and SNRIs. It is also important to avoid alcohol while taking this medication, as it can increase the risk of side effects. Always consult a healthcare provider before starting or stopping any medication.

Frequently Asked Questions

Fetzima 40 mg is used for the management of major depressive disorder (MDD). It helps to balance certain chemicals in the brain that may be unbalanced in people with depression.

Fetzima 40 mg should be taken orally, usually once daily, with or without food. The capsules should be swallowed whole and not crushed or chewed.

Common side effects may include nausea, dry mouth, constipation, increased sweating, dizziness, and insomnia. These effects can vary and may subside over time.

It is generally advised to avoid alcohol while taking Fetzima 40 mg, as it can increase the risk of side effects.

Fetzima 40 mg should be stored at room temperature, away from moisture and heat. Keep the medication in its original container and out of reach of children.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.